Show Advanced FiltersHide Advanced Filters
Use filters to refine the search results.
ResetAdd New FilterSearch
Now showing items 1-8 of 8
Cellular Virotherapy Increases Tumor-Infiltrating Lymphocytes (TIL) and Decreases their PD-1+ Subsets in Mouse Immunocompetent Models.
Cellular Heterogeneity and Cooperativity in Glioma Persister Cells Under Temozolomide Treatment
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma
AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses
Clonal dynamics in osteosarcoma defined by RGB marking
SOX2 Expression and Transcriptional Activity Identifies a Subpopulation of Cancer Stem Cells in Sarcoma with Prognostic Implications
Sarcoma treatment in the era of molecular medicine.
Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice